Join the club for FREE to access the whole archive and other member benefits.

Shionogi

Japanese pharmaceutical company best known for developing Crestor.

Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages our science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.

At Shionogi Inc., we’re intensely focused on developing and commercializing the scientific breakthroughs emerging from our research laboratories in Japan as well as discoveries of our strategic alliance partners. We couple our innovative discovery base with capabilities to advance drug candidates rapidly from lab to clinic to patient, forming, where appropriate, bold new partnerships to accelerate and amplify the availability of these new medications to patients around the world.

Visit website: https://www.shionogi.com/

 shionogi-inc-

 UCXZvo7q7xhx_b4w8XSWieoA

Details last updated 27-Mar-2020

People at Shionogi

Simon Portsmouth

Executive Medical Director at Shionogi Inc

Shionogi News

Experimental Drug Kills Flu Virus in a Single Day

ScienceAlert - 13-Feb-2018

Shionogi claims its influenza virus treatment is faster-acting than any other flu drug. One dose...

Read more...
Topics mentioned on this page:
Laboratory Automation